Meeting News CoverageVideo

VIDEO: Spliceosomal mutations may be valuable target in myeloid leukemias

ORLANDO, Fla. — Hetty Carraway, MD, reacts to a plenary abstract presented at the ASH Annual Meeting and Exposition that assessed the value of targeting spliceosomal mutations in myeloid leukemias. “This is very exciting for the future of our patients with myeloid leukemias, and we are eager to move forward with these clinical studies in the upcoming year,” Carraway said.

ORLANDO, Fla. — Hetty Carraway, MD, reacts to a plenary abstract presented at the ASH Annual Meeting and Exposition that assessed the value of targeting spliceosomal mutations in myeloid leukemias. “This is very exciting for the future of our patients with myeloid leukemias, and we are eager to move forward with these clinical studies in the upcoming year,” Carraway said.

    See more from ASH Annual Meeting and Exposition